Clinical Trial Update: 18-Month Study of Memory Effects of Curcumin [Phase 2]

View source ↗

Summary

A Phase 2 study assessing the memory effects of curcumin over 18 months in older adults with age-associated cognitive impairment and mild cognitive impairment, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-associated Cognitive Impairment
• Cognitive Impairment

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Age-associated Cognitive Impairment, Mild Cognitive Impairment (MCI) | Phase 2 | Status: COMPLETED | Results posted: 2018-03-19